Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 245 of 6351
-
New asthma drug could let patients ditch daily steroid pills
Disease control CompletedThis is a study designed to evaluate efficacy and safety of Tezepelumab in reducing oral corticosteroid use in adult patients with severe asthma who are receiving oral corticosteroids with or without additional asthma controller medications.
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could less radiation be enough for HPV throat cancer?
Disease control Recruiting nowThis study builds on the results of several prior studies that we have been involved with to test the hypothesis that Risk-Adapted De-Intensification of Radiation Therapy and chemotherapy based on HPV subtype, plasma circulating free HPV DNA (cfHPV DNA) level, and cfHPV DNA clear…
Phase 2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Promising cocktail may turn inoperable stomach cancer into surgical candidates
Disease control OngoingThis is a phase II study to evaluate the efficacy and safety of combination of fruquintinib (VEGFR 1/2/3 inhibitor), sintilimab (PD-1 inhibitor) and SOX conversion therapy in unresectable advanced gastric cancer patients.
Phase 2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can Anti-Inflammatory drugs lift depression that Won't budge?
Disease control CompletedThis randomized controlled study was conducted to compare the effectiveness of minocycline and celecoxib as add-on treatments in patients with treatment-resistant major depressive disorder. Treatment-resistant depression was defined as depression that had not adequately improved …
Sponsor: Lahore General Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New booster aims to shield the vulnerable from COVID-19
Vaccine CompletedA phase IIb/III, open label, single arm, multi-centre, trial to assess the immunogenicity and safety of an additional dose vaccination with a recombinant protein RBD fusion heterodimer candidate (PHH-1V) against SARS-CoV-2, in adults with pre-existing immunosuppressive conditions…
Phase 2/3 • Sponsor: Hipra Scientific, S.L.U • Aim: Vaccine
Last updated Jun 26, 2026 18:38 UTC
-
Lab-Grown stem cells could speed immune recovery in blood cancer transplants
Disease control OngoingThis phase II trial studies how well donor umbilical cord blood transplant with ex-vivo expanded cord blood progenitor cells (dilanubicel) works in treating patients with blood cancer. Before the transplant, patients will receive chemotherapy (fludarabine, cyclophosphamide and in…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a soap Opera–Style parenting program curb teen depression and suicide?
Prevention Recruiting nowThe goal of this study is to evaluate in an effectiveness-implementation type I hybrid trial, an enhanced version of eHealth Familias Unidas for reducing depressive, anxious symptoms and suicide behavior in Hispanic youth. The study will use a randomized rollout design with 18 pe…
Sponsor: University of Miami • Aim: Prevention
Last updated Aug 20, 2026 00:00 UTC
-
A wearable patch could unmask silent heart rhythm that raises stroke risk
Diagnosis CompletedThis study aimed to detect and diagnose atrial fibrillation early by conducting a screening test for atrial fibrillation using a continuous electrocardiography monitoring device for those who have undergone a health screening examination. Early detection through atrial fibrillat…
Sponsor: Seoul National University Hospital • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
New hope for hard-to-treat lymphoma: drug duo aims to shrink tumors and delay progression
Disease control OngoingThis study will assess the efficacy and safety of mosunetuzumab in combination with polatuzumab vedotin (M+P) in participants with relapsed or refractory (R/R) diffuse-large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma, transformed follicular lymphoma (trFL) and FL Grade 3…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can six short writing sessions ease PTSD in underserved patients?
Symptom relief OngoingPosttraumatic stress disorder (PTSD) is a significant problem among underserved populations who receive care in community health centers. Several evidence-based psychotherapies for PTSD are not practical given the time and resources required for these approaches. This research wi…
Sponsor: RAND • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can higher doses and steroids beat TB in HIV patients?
Disease control CompletedDATURA trial is a phase III, multicenter, two-arm, open-label, randomized superiority trial to compare the efficacy and the safety of an intensified tuberculosis (TB) regimen versus standard TB treatment in HIV-infected adults and adolescents hospitalized for TB with CD4 ≤ 100 ce…
Phase 3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a daily pill stop hereditary angioedema attacks?
Disease control Stopped earlyThis study evaluates the safety and efficacy of PHA-022121 administered orally for prophylaxis against angioedema attacks in patients with hereditary angioedema (HAE). The study consists of 2 parts, with patients completing participation in Part 1 prior to initiation of treatment…
Phase 2 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a meningitis shot also stop gonorrhea?
Disease control CompletedThis is a double-blind randomized controlled trial to test whether the group B meningitis vaccine 4 component Neisseria meningitidis serogroup B vaccine (BEXSEROTM) (4C-MenB), trade name Bexsero™), currently approved for use by the United States Food and Drug Administration (FDA)…
Phase 2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
Disease control Recruiting nowThis is a multicenter, open-label phase 1/2a study consisting of two parts: dose escalation phase and dose expansion phase. The objective of the dose escalation phase is to evaluate the safety, tolerability and pharmacokinetics of JAB-21822 in combination with JAB-3312 in patient…
Phase 1/2 • Sponsor: Allist Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New Muscle-Boosting drug shows promise for SMA patients in major trial
Disease control CompletedThis Phase 3 trial (Study SRK-015-003) was conducted in patients ≥2 years old at Screening, who were previously diagnosed with later-onset spinal muscular atrophy (SMA) (i.e., Type 2 and Type 3 SMA) and were receiving an approved survival motor neuron (SMN) upregulator therapy (i…
Phase 3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New cancer vaccine Modi-1 enters human trials for four tumor types
Vaccine Recruiting nowThe main objectives of this study are to assess the safety, tolerability, immunological activity, and preliminary efficacy of the Modi-1 Moditope vaccine, both as monotherapy and in combination with a checkpoint inhibitor (CPI) such as pembrolizumab or nivolumab with or without I…
Phase 1/2 • Sponsor: Scancell Ltd • Aim: Vaccine
Last updated Jun 26, 2026 18:32 UTC
-
Heated chemo during surgery may extend life for Drug-Resistant ovarian cancer
Disease control OngoingPlatinum-resistant recurrent epithelial ovarian cancer randomizing with or without cytoreductive surgery + hyperthermic intraperitoneal chemotherapy (HIPEC): KOV-02R, RECOVER
Phase 3 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Spinal stimulation trial aims to restore movement and bladder control after injury
Disease control Recruiting nowThe loss of movement and walking ability significantly affects quality of life after spinal cord injury. In addition, bladder dysfunction consistently ranks as one of the top disorders affecting quality of life after spinal cord injury. The overall objective of this study is to d…
Sponsor: Claudia Angeli • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New Once-Weekly shot could prevent bleeds in kids with hemophilia
Disease control CompletedThis study is looking at how Mim8 works compared to other medicines in children with haemophilia A, who either have inhibitors or do not have inhibitors. Mim8 is a new medicine that will be used for prevention of bleeds. Mim8 will be injected with a thin needle into the skin. Th…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New pill shows promise in rare cancer fight
Disease control CompletedThis study is open to people with a type of cancer called dedifferentiated liposarcoma. People with advanced liposarcoma aged 18 or older who are not receiving any other cancer treatment can participate. The purpose of this study is to compare a medicine called brigimadlin (BI 9…
Phase 2/3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC